Welcome page

Job Listings


Here are our current job openings. Please click on the job title for more information, and apply from that page if you are interested.

Current Dendreon Employees: Please apply using the internal career site available through the intranet.

Use this form to perform another job search

The system cannot access your location for 1 of 2 reasons:
  1. Permission to access your location has been denied. Please reload the page and allow the browser to access your location information.
  2. Your location information has yet to be received. Please wait a moment then hit [Search] again.
Click column header to sort

Search Results Page 1 of 1

Location : Location US-CA-Seal Beach
Job ID 2024-2968
Job Title

Sr Manager, Quality Assurance & Supplier Quality
Who we are. Dendreon is making the battle against cancer personal. Our flagship product PROVENGE® (sipuleucel-T), was the first FDA approved immunotherapy for the treatment of metastatic castrate resistant prostate cancer and is made from the patient's own immune cells.  
Minimum
USD $150,016.00/Yr.
Maximum
USD $183,769.60/Yr.
Location : Location US-WA-Seattle
Job ID 2024-2965
Job Title

Director, Process Sciences Cell Therapy
Who we are. Dendreon is making the battle against cancer personal. Our flagship product PROVENGE® (sipuleucel-T), was the first FDA approved immunotherapy for the treatment of metastatic castrate resistant prostate cancer and is made from the patient's own immune cells.   If you are looking to positively impact the lives of patients, we want you to join our team. We have Immunotherapy Manufacturing Facilities...
Minimum
USD $180,800.00/Yr.
Maximum
USD $221,480.00/Yr.
Location : Location US-CA-Seal Beach
Job ID 2024-2962
Job Title

Manager, Sales Operations
Who we are. Dendreon is making the battle against cancer personal. Our flagship product PROVENGE® (sipuleucel-T), was the first FDA approved immunotherapy for the treatment of metastatic castrate resistant prostate cancer and is made from the patient's own immune cells.  
Minimum
USD $109,600.00/Yr.
Maximum
USD $134,260.00/Yr.
Location : Location US-WA-Seattle
Job ID 2024-2960
Job Title

Scheduling - Logistics Case Manager
Who we are. Dendreon is making the battle against cancer personal. Our flagship product PROVENGE® (sipuleucel-T), was the first FDA approved immunotherapy for the treatment of metastatic castrate resistant prostate cancer and is made from the patient's own immune cells.  
Minimum
USD $64,400.00/Yr.
Maximum
USD $78,890.00/Yr.
Location : Location US-NY-New York City
Job ID 2024-2959
Job Title

Patient Navigation Educator (MN, IL, OH, NY, PA, IN, MA)
Who we are. Dendreon is making the battle against cancer personal. Our flagship product PROVENGE® (sipuleucel-T), was the first FDA approved immunotherapy for the treatment of metastatic castrate resistant prostate cancer and is made from the patient's own immune cells.   If you are looking to positively impact...
Location : Location US-Boston, MA
Job ID 2024-2954
Job Title

Medical Science Liaison - Northeast (Covers MN, IA,MO,WI,IL,MI,IN,OH,PA,NY,VT,MA,CT,NH,NJ,RI,ME)
Who we are. Dendreon is making the battle against cancer personal. Our flagship product PROVENGE® (sipuleucel-T), was the first FDA approved immunotherapy for the treatment of metastatic castrate resistant prostate cancer and is made from the patient's own immune cells.   If you are looking to positively impact...
Location : Location US-WA-Seattle
Job ID 2024-2950
Job Title

Clinical Research Associate II
Who we are. Dendreon is making the battle against cancer personal. Our flagship product PROVENGE® (sipuleucel-T), was the first FDA approved immunotherapy for the treatment of metastatic castrate resistant prostate cancer and is made from the patient's own immune cells.  
Minimum
USD $85,600.00/Yr.
Maximum
USD $104,860.00/Yr.
Location : Location US-CA-Seal Beach
Job ID 2024-2948
Job Title

Director, Ethics, Risks & Compliance
Who we are. Dendreon is making the battle against cancer personal. Our flagship product PROVENGE® (sipuleucel-T), was the first FDA approved immunotherapy for the treatment of metastatic castrate resistant prostate cancer and is made from the patient's own immune cells.  
Minimum
USD $188,688.00/Yr.
Maximum
USD $231,142.80/Yr.